6.2.1.4 Changes in the composition of the Board of Directors and its Committees during Fiscal 2021 and changes planned for Fiscal 2022
Changes during Fiscal 2021
| |
DEPARTURE |
APPOINTMENT |
REAPPOINTMENT |
| Board of Directors |
Board of Directors DEPARTUREJanuary 12, 2021 : Soumitra Dutta |
Board of Directors APPOINTMENTJanuary 12, 2021 : Federico J. Gonzalez Tejera |
Board of Directors REAPPOINTMENTJanuary 12, 2021 :
Sophie Bellon
Nathalie Bellon-Szabo
Françoise Brougher |
| Audit Committee |
Audit Committee DEPARTUREJanuary 12, 2021 : Soumitra Dutta |
Audit Committee APPOINTMENTOctober 28, 2020: Véronique Laury |
Audit Committee REAPPOINTMENT- |
| Compensation Committee |
Compensation Committee DEPARTURE- |
Compensation Committee APPOINTMENT- |
Compensation Committee REAPPOINTMENT- |
| Nominating Committee |
Nominating Committee DEPARTURE- |
Nominating Committee APPOINTMENT- |
Nominating Committee REAPPOINTMENT- |
Changes planned for Fiscal 2022
At the Combined Annual Shareholders Meeting on December 14, 2021, the Board of Directors will recommend that shareholders :
- reappoint François-Xavier Bellon as director for an additional three-year term.
François-Xavier Bellon is recognized for his operational and financial expertise as well as for his long-term strategic vision, fully in line with the expertise sought by the Board of Directors, even more so during the current context of accelerating the Group’s transformation. He has demonstrated great rigor over the duration of his mandate, notably during the sanitary crisis related to the Covid-19 pandemic.
Emmanuel Babeau, whose term of office expires at the close of the December 14, 2021 Annual Shareholders Meeting, has stated that he does not wish to be reappointed after 6 years of tenure;
- appoint a new independent director, Jean-Baptiste Chasseloup de Chatillon, for a three year term. Jean-Baptiste Chasseloup de Chatillon, of French nationality, is Executive Vice President and Chief Financial Officer of Sanofi since 2018. Before joining Sanofi, he was Chief Financial Officer and Member of the Management Board and of the Executive Committee of PSA Peugeot Citroën, where he spent nearly 30 years and held finance, commercial and operational roles, in various European countries. Heled major merger and acquisition transactions with American, Russian, Chinese, Indian and European companies. Jean-Baptiste Chasseloup de Chatillon’s biography below provides additional information on his background.
On October 26, 2021, the Board of Directors also decided to appoint Luc Messier as a new member of the Nominating Committee. He will bring his strong understanding of different cultures given his experience living and working in several countries in Europe, Asia and North America.
The Board also decided that, subject to his appointment as a director at the Shareholders Meeting of December 14, 2021, Jean-Baptiste Chasseloup de Chatillon would join the Audit Committee.
